Ultragenyx Pharmaceutical Inc. buy Wells Fargo & Company
Start price
30.12.25
/
50%
€17.00
Target price
30.12.26
€38.21
Performance (%)
6.47%
Price
31.03.26
€16.90
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan shows slight gains of 6.47%. This prediction currently runs until 30.12.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -1.170% | -1.170% |
| iShares Core DAX® | 0,75 % | -8,50 % |
| iShares Nasdaq 100 | -1,41 % | -2,77 % |
| iShares Nikkei 225® | 0,42 % | -9,29 % |
| iShares S&P 500 | -0,59 % | -2,87 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Wells Fargo & Company from $65.00 to $45.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€29.20
20.10.25
20.10.25
€55.74
20.10.26
20.10.26
-38.01%
31.03.26
31.03.26
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€26.00
10.07.25
10.07.25
€55.35
10.07.26
10.07.26
-30.38%
31.03.26
31.03.26
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€41.80
20.12.24
20.12.24
€84.54
20.12.25
20.12.25
-32.06%
21.12.25
21.12.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.20
02.08.24
02.08.24
€68.71
02.08.25
02.08.25
-46.75%
03.08.25
03.08.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€37.60
08.12.23
08.12.23
€66.97
08.12.24
08.12.24
23.94%
09.12.24
09.12.24